Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00208936
NCT00208936
Terminated
Phase 2

Phase II Study of Pre-Operative Chemotherapy With Taxol, Cisplatin, and 5-Fluorouracil Followed by G-CSF in Patients With Resectable Local-Regional Carcinoma of Esophagus

Emory University1 site in 1 country20 target enrollmentJanuary 1996
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsEsophageal Diseases
DrugsTaxol, Cisplatin, 5-Fluorouracil, G-CSF

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Esophageal Diseases
Sponsor
Emory University
Enrollment
20
Locations
1
Status
Terminated
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This study is designed pre-operative for patients with resectable, local-regional carcinoma of the esophagus.

Detailed Description

This study is designed for patients with resectable, local-regional carcinoma of the esophagus. In a pre-operative setting, chemotherapy with Taxol, Cisplatin, and 5-Fluorouracil will be administered followed by G-CSF.

Registry
clinicaltrials.gov
Start Date
January 1996
End Date
March 2006
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nabil F. Saba

Associate Professor

Emory University

Eligibility Criteria

Inclusion Criteria

  • •Measurable disease with resectable local-regional carcinoma of the esophagus. 18 years of age or older.

Exclusion Criteria

  • •Pregnant or lactating. Non-resectable local-regional carcinoma of the esophagus.

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials

Terminated
Phase 2
Neo-Adjuvant FOLFOX for Rectal CarcinomaRectal Neoplasms
NCT00832299Beth Israel Medical Center2
Recruiting
Phase 2
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic CancerPancreas AdenocarcinomaResectable Pancreatic Cancer
NCT03492671Loma Linda University30
Completed
Phase 2
Phase II study of pre-operative chemoradiation using S-1 followed by surgical resection for potentially resectable and locally advanced pancreatic cancerPotentially resectable and locally advanced pancreatic cancer
JPRN-UMIN000003088Department of Surgery, Kansai Medical University Hirakataka Hospital30
Recruiting
Phase 2
Phase II study of perioperative chemotherapy (preoperative XELOX+Bevacizumab/ postoperative XELOX) in patients with locally advanced rectal cancerRectal cancer
JPRN-UMIN000013000Sano Hospital Masahito Kotaka, MD50
Completed
Phase 2
Preoperative Chemoradiotherapy and MK-3475 for Esophageal Squamous Cell Carcinoma (ACTS-29)Esophageal Squamous Cell Carcinoma
NCT02844075Yonsei University28